Sawyer C, Peto R, Bernstein L, Pike M C
Biometrics. 1984 Mar;40(1):27-40.
An index of carcinogenic potency for chemicals tested in chronic animal experiments is described. By analogy with the well-known 'lethal dose 50' (LD50) of quantal bioassay, a 'tumorigenic dose 50' (TD50) may be defined (in the absence both of tumors in the control group and of intercurrent deaths) as that (daily) dose of chemical which gives 50% of the test animals tumors by some fixed age. Tumors in the control (zero-dose) group are handled exactly as for the LD50, and intercurrent deaths are handled by life-table methods. Nonparametric procedures are developed for estimating the TD50 and for constructing confidence intervals. These are based on likelihoods which assume that the tumor hazard is linear in dose.
本文描述了一种用于在慢性动物实验中测试的化学物质致癌效力指数。类比于定量生物测定中广为人知的“半数致死剂量”(LD50),可以定义“半数致瘤剂量”(TD50)(在对照组无肿瘤且无并发死亡的情况下)为在某个固定年龄使50%的实验动物发生肿瘤的(每日)化学物质剂量。对照组(零剂量组)的肿瘤处理方式与LD50完全相同,并发死亡则采用生命表方法处理。开发了用于估计TD50和构建置信区间的非参数程序。这些程序基于假设肿瘤风险在剂量上呈线性的似然性。